Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-04-02
2010-11-16
Bradley, Christina (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S007100
Reexamination Certificate
active
07833983
ABSTRACT:
The present invention relates to a peptide comprising a symmetrical dimethylated arginine, and constitute an immunologic determinant of antibodies present in sera from patients with systemic lupus erythematosus (SLE), and wherein the methylation is a prerequisite for reacting with said antibodies. The invention also relates to the use of said peptide for diagnosis of SLE and the differentiation between SLE and MCTD.
REFERENCES:
patent: 2002/0165355 (2002-11-01), Meheus et al.
Abuaf, N., Johanet, C, Chretien, P, Absalon, B. 1., Homberg, J. C., Buri, J. F. , “Detection of autoantibodies to Sm antigen in systemic lupus erythematosus by immunodiffusion, ELISA and immunoblotting: variability of incidence related to assays and ethnic origin of patients”,European Journal of Clinical Investigation1990 20(4) pp. 354-359.
Arbuckle, M. R., Reichlin, M, Harley, J. B, James, J. A., “Shared early autoantibody recognition events in the development of anti-Sm B/B in human lupus”,Scandinavian Journal of Immunology, 1999 50(5) pp. 447-455.
Arnett, F. C.,Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F, Cooper, N. S., Healey, L. A, Kaplan, S. R, Liang, M. H, Luthra, H. S., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis”,Arthritis&Rheumatism, 1988 3 1(3) pp. 315-324.
Arnett, F. C., Hamilton, R. G, Roebber, M. G, Harley, J. B, Reichlin, M., “Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus”,Journal of Rheumatology, 1988 15(12) pp. 1773-1776.
Bloom, D. D, Davignon, J. L, Cohen, P. L, Elsenberg, R. A, Clarke, S. H., “Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice”,Journal of Immunology, 1993 150(4) pp. 1579-1590.
Brahms, H, Raker, V. A, van Venrooij, W. J, Luhrmann, R., “A major, novel systemic lupus erythematosus autoantibody class recognizes the E, F, and G Sm snRNP proteins as an E-F-G complex but not in their denatured states”,Arthritis&Rheumatism, 1997 40(4) pp. 672-682.
Brahms, H, Raymackers, J, Union, A, de Keyser, F, Meheus, L, Luhrmann, R., “The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies”,J Biol Chem, 2000 275(22) pp. 17122-17129.
Brahms, H, Meheus, L, De Brabandere, V, Fischer, U, Luhrmann, R., “Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B and the Sm-like protein LSm4, and their interaction with the SMN protein”,Rna-A Publication of the Rna Society, 2001 7 (11) pp. 1531-1542.
Sabbatini, A, Bombardieri, S, Migliorini, P., “Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and EpsteinBarr virus-encoded nuclear antigen EBNA 1”,European Journal of Immunology, 1993 23(5) pp. 1146-1152.
Sabbatini, A, Doicher, M. P, Marchini, B, Bombardieri, S, Migliorini, P., “Mapping of epitopes on the SniD molecule: the use of multiple antigen peptides to measure autoantibodies in systemic lupus erythematosus”,Journal of Rheumatology, 1993 20(10) pp. 1679-1683.
Seraphin, B., “Sm and Sm-like proteins belong to a large family: identification of proteins of the U6 as weil as the U1, U2, U4 and U5 snRNPs”,Embo J, May 1, 1995 14(9) pp. 2089-2098.
Tan, E. M, Kunkel, H. G., “Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus”,Journal of Immunology, 1966 96(3) pp. 464-471.
Tan, E. M, Cohen, A. S, Fries, J. F, Masi, A. T, McShane, D. J, Rothfield, N. F, Schaller, J. G, Talal, N, Winchester, R. J, “The 1982 revised criteria for the classification of systemic lupus erythematosus”,Arthritis&Rheumatism, 1982 25(11) pp. 1271-1277.
von Muhlen, C. A, Tan, E. M., “Autoantibodies in the diagnosis of systemic rheumatic diseases”,Seminars in Arthritis&Rheumatism, 1995 24(5) pp. 323-358.
Ou, Y, Sun, D, Sharp, G. C, Hoch, S. O, “Screening of SLE sera using purified recombinant Sm-D1 protein from a baculovirus expression system”,Clinical Immunology&Immunopathology, 1997 83 (3) pp. 310-317.
Zhang, W., Reichlin, M., “IgM anti-A and D SnRNP proteins and IgM anti-dsDNA are closely associated in SLE sera”,Clinical Immunology&Immunopathology, 1995 74(1) pp. 70-76.
Anonymous, “Preliminary criteria for the classification of systemic scierosis (scieroderma). Subcommittee for scieroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee”,Arthritis&Rheumatism, 1980 23(5) pp. 581-590.
Mahler, M, Mierau, R, Schiumberger, W, Bluthner, M., “A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1”,Journal of Molecular Medicine, 2001 79(12) pp. 722-731.
Marchini, B, Doicher, M. P, Sabbatini, A, Klein, G, Migliorini, P., “Immune response to different sequences of the EBNA 1 molecule in Epstein-Barr virus-related disorders and in autoimmune diseases”,Journal of Autoimmunity, 1994 7(2) pp. 179-191.
McClain, M. T, Ramsiand, P. A, Kaufman, K. M, James, J. A., “Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens”,Journal of Immunology, 2002 168(4) pp. 2054-2062.
Panush, R. S, Edwards, N. L, Longley, S, Webster, E., “‘Rhupus’ syndrome”,Archives of Internal Medicine, 1988 148(7) pp. 1633-1636.
Reichlin, M, Martin, A, Taylor-Albert, E, Tsuzaka, K., Zhang, W., Reichlin, M. W., Koren, E., Ebling, F. M., Tsao, B., Hahn, B. II, “Lupus autoantibodies to native DNA cross-react with the A and D SnRNP polypeptides”,J Clin Invest, Jan. 1994 93(1) pp. 443-449.
Riemekasten, G, Marell, J, Trebeljahr, G, Klein, R, Hausdorf, G, Haupi, T., Schneider-Mergener, J., Burmester, G. R., Hiepe, F., “A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus”,J Clin Invest, Aug. 15, 1998 102(4) pp. 754-763.
Riemekasten, G., Kawald, A., Weiss, C., Meine, A., Marell, J., Klein, R., Hocher, B., Meisel, C., Hausdorf, G., Manz, R., Kamradt, T., Burmester, G. R., Hiepe, F., “Strong acceleration of murine lupus by injection of the SmD1(83-1 19) peptide”,Arthritis&Rheumatism, 2001 44(10) pp. 2435-2445.
Rokeach, L. A., Haselby, J. A., Hoch, S. O., “Molecular cloning of a cDNA encoding the human Sm-D autoantigen”,Proc Natl Acad Sci U S A, Jul. 1988 85(13) pp. 4832-4836.
Rokeach, L. A., Jannatipour, M, Haselby, J. A. Hoch, S. O., “Mapping of the immunoreactive domains of a small nuclear ribonucleoprotein-associated Sm-D autoantigen”,Clinical Immunology&Immunopathology, 1992 65(3) pp. 315-324.
Rokeach, L. A., Hoch, S. O., “B-cell epitopes of Sm autoantigens”,Molecular Biology Reports, 1992 16(3) pp. 165-174.
De Keyser, F., Hoch, S. O., Takei, M., Dang, H., De Keyser, II., Rokeach, L. A., Talal, N, “Cross-reactivity of the B/B′ subunit of the Sm ribonucleoprotein autoantigen with proline-rich polypeptides”,Clinical Immunology&Immunopathology, 1992 62(3) pp. 285-290.
Gausepohl, fl., Behn, C., Automated synthesis of solid—Phase bound peptides. In “Peptides arrays on membrane supports, synthesis and applications”,J Koch and M. Mahler, Eds, pp. 55-68, Springer Verlag, Heidelberg, New York, 2002.
Greidinger, E. L., Hoffman, R. W., “The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B′fB proteins as predominant U1 RNP immunogens”,Arthritis&Rheum
Bradley Christina
Phadia AB
Porter Wright Morris & Arthur LLP
LandOfFree
Analytical method and kit thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analytical method and kit thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analytical method and kit thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168674